|
**New Chief Executive for PHG Foundation will boost focus on international health**
The Foundation is governed by its Board of Directors, currently: |
Baroness Onora O'Neill CBE PBA
Formerly Principal of Newnham College, she is Professor of Philosophy at the University of Cambridge, President of the British Academy, and Chair of the Nuffield Foundation. She works mainly in ethics and political philosophy. She has been a member of the Nuffield Council on Bioethics and the Human Genetics Advisory Commission, and was closely involved in work on a number of reports on biomedical issues. She was created a life peer in 1999 (Baroness O’Neill of Bengarve), and sits as a crossbencher.
|
Ian Peacock
Ian Peacock is Chairman of Mothercare plc and is also Deputy Chairman of Lombard Risk Management plc. He is a Trustee of the WRVS and Chairman of the Financial Advisory Committee for Westminster Abbey. Ian was previously Chairman of Galiform PLC (formerly MFI Furniture Group) and has also held a number of senior positions in the banking industry in London, New York and Asia with Kleinwort Benson Group and with BZW. He was also a special adviser to the Bank of England from 1998 – 2000, and a non-executive director of Norwich and Peterborough Building Society until 2005
|
Professor Sir Brian Heap CBE ScD FRS
Brian Heap is an Honorary Fellow at St Edmund’s College, Cambridge and a Research Associate of its Capability and Sustainability Centre. He is Editor of the Philosophical Transactions of the Royal Society (Biological Sciences), Special Professor at the University of Nottingham, Principal Scientific Adviser to ZyGEM Ltd of New Zealand, and a trustee of various organisations. He holds doctorates from the Universities of Nottingham and Cambridge, and has published in endocrine physiology, reproductive biology, biotechnology, sustainable consumption and production, science advice and science policy issues. Formerly, he was Master of St Edmund’s College, Vice-President and Foreign Secretary of the Royal Society, Director of Research at the Biotechnology and Biological Sciences Research Council, President of the Institute of Biology, UK Representative on the European Science Foundation, UK Representative on the NATO Science Committee, Chair of the Cambridge Genetics Knowledge Park, and a member of the Advisory Board of the Templeton Foundation and a judge of the Templeton Prize. Sir Brian served on the Nuffield Council on Bioethics, the Department of Health’s Expert Group on Cloning; has worked on developing country issues particularly in China with the World Health Organisation, and was scientific consultant for Merck, Sharp and Dohme, Johnson and Johnson, and Ligand Pharmaceuticals in the USA.
|
Sir Keith Peters FRS PMedSci
Sir Keith Peters is Emeritus Professor of Physic at the University of Cambridge, where he was Head of the School of Clinical Medicine and Honorary Consultant Physician at Addenbrooke's NHS Trust from 1987-2005. His research interests centre on the translation of basic medical science into clinical practice. He is a founding Fellow and President of the Academy of Medical Sciences and Fellow of the Royal Society. In March 2004 he was appointed to the Council of Science and Technology, of which he is currently co-Chairman. He is a Senior Consultant to GlaxoSmithKline and Chair of the Council of Cardiff University.
|
Dr Ron Zimmern MA FRCP FFPHM
Ron Zimmern trained as a doctor at Trinity College, Cambridge and the Middlesex Hospital, London. After specialising in neurology he obtained a law degree and entered public health medicine in 1983. Following seven years as Director of Public Health for Cambridge and Huntingdon Health Authority, he established the Public Health Genetics Unit in Cambridge in June 1997 with seed funding from the Cambridge health community. In 2002 he secured government funding for five years from the Genetics Knowledge Park programme to expand his team’s pioneering work in public health genomics.
Ron is Chairman of the Diagnostic and Screening Panel of the UK’s Health Technology Assessment programme, serves on the Genetics Commissioning Advisory Group and the Steering Group for the National Genetic Testing Network at the Department of Health, and is on the Council for the British Society of Human Genetics. He is also an Associate Lecturer and Director of the Institute of Public Health at the University of Cambridge.
Aside from public health genomics, Ron’s interests include strategic planning, the relationship between clinical services and teaching and research, priority setting in the NHS, and the law and ethics of medicine.
|
Sarah Squire
Sarah Squire has been President of Hughes Hall, University of Cambridge since 2006. She read History at Cambridge (Newnham College) and then entered HM Diplomatic Service. Her work as a diplomat took her to Israel, Washington, Senegal and then, with a focus on the countries of eastern Europe and former Yugoslavia, to Macedonia and Croatia. From 2000-2003 she was HM Ambassador in Estonia.
In addition to her responsibilities for Hughes Hall, Sarah Squire has a number of other University duties, including as a Deputy Vice Chancellor, as Chairman of the Centre for Family Research and Chairman of the Biology Faculty Appointments Board. She is also connected with University College London where she is on the Advisory Board of the School of Slavonic and South East European Studies.
|